263 filings
Page 4 of 14
8-K
34z18piz9m5v
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
zrmyd23ky km
1 Jul 21
Other Events
6:11am
8-K
mlxbp2 tt
14 Jun 21
Other Events
5:21pm
8-K
xqyiwh26z9 l2j
26 May 21
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing
10:17am
8-K
fxpmr
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
cu7xo15
21 May 21
Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich’s Ataxia
7:28am
8-K
v50fzz
18 May 21
Other Events
3:09pm
8-K
n5lb d8bjn
17 May 21
Submission of Matters to a Vote of Security Holders
6:08am
8-K
nr0zej3o5e99itdrnib
11 May 21
Other Events
8:34am
8-K
vo2imk2wbfguu00qreh
10 May 21
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
4:15pm
8-K/A
8ycl2ep
4 Mar 21
Unaudited Pro Forma Combined Financial Statements
5:16pm
8-K
xouyk12
4 Mar 21
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
7:30am
8-K
mdcsyc6yymdfvxmenarp
8 Dec 20
Regulation FD Disclosure
7:40am
8-K/A
03twi
12 Nov 20
Unaudited Pro Forma Combined Financial Statements
4:51pm
8-K
0uu ipgyy
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm